NeuroAge Therapeutics
PrivateLast Round
Pre Seed
Feb 16, 2026
Total Funding Raised
$449,817
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeuroAge Therapeutics is a biotechnology company that operates a platform to assess and reverse brain aging, helping reduce the risk of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroAge Therapeutics Comparables
Compare NeuroAge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainKey | 76% | |
| Linus Health | 64% | |
| AcroViz | 64% | |
NeuroAge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 16, 2026 | ||||
| Grant | Feb 1, 2024 | ||||
| Accelerator | Nov 1, 2023 |
NeuroAge Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Propel(x) | Pre Seed |
| Gates Ventures | Pre Seed |
| R42 Group | Pre Seed |
| Alzheimer's Drug Discovery Foundation | Pre Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 63% MoM.
- Jun 15, 2026
Grew 27% QoQ, from 15 to 19 employees.
NeuroAge Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroAge Therapeutics's valuation, stock price, and market status.